Roche's Itovebi was the first PI3K inhibitor to get approved as a first-line treatment for breast cancer last year – and new survival data to be presented at the upcoming ASCO congress looks set ...

Petros Grivas, MD, PhD, expresses great enthusiasm for the 2025 ASCO Annual Meeting, highlighting its wealth of clinical trial data, educational sessions, and real-world insights. He is ...

Dr Chavez MacGregor eagerly awaits the 2025 ASCO Annual Meeting, especially the sessions on early-stage breast cancer. She highlights new data on treatment optimization for HER2-positive disease ...

"Bristol Myers Squibb is advancing novel approaches to address high unmet needs in cancer and at this year’s ASCO meeting, we are highlighting data across a range of assets, including our ...

ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO ...

ALEXANDRIA, Va., and SUNNYVALE, Calif., May 21, 2025 /PRNewswire/ -- The American Society of Clinical Oncology (ASCO) and Google Cloud today announced a powerful collaboration to launch an AI ...

The evidence base consisted of 52 systematic reviews (42 for exercise, nine for diet, and one for weight management), and an additional 23 randomized controlled trials. The most commonly studied types ...

Mario Aguilar covers technology in health care, including artificial intelligence, virtual reality, wearable devices, telehealth, and digital therapeutics. His stories explore how tech is changing ...

will be presented by Eisai at the American Society of Clinical Oncology (ASCO) Congress 2025, held in Chicago, USA from May 30 to June 3, 2025. The abstract of the study has been released today. To ...

Gilead Sciences, Inc. (NASDAQ:GILD) plans to present over 20 research abstracts—spanning both Gilead and its cell therapy unit Kite—at two major medical conferences: the 2025 ASCO Annual ...

A supervised exercise already shown to alleviate fatigue and other side effects in patients with metastatic breast cancer has now been found to also be cost analysis. Anne May, PhD, of Utrecht ...

Valve's MOBA hero shooter Deadlock is still in an invite-only testing phase, as the company continues to develop and iterate. But a recent livestream mix-up looks like it revealed the existence of ...